Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.50 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.44 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7856287 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856285 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856294 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856305 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856303 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL10017358 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856919 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856296 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL1815001 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 | |
| SCHEMBL7856917 | 1.00 | PTPN1 (0.52) | PTPN1TBXAS1BLMTSHRGABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410396-A | Solid viologen organic electrochromic material and electrochromic device | 深圳市华科创智技术有限公司 | 2023-07-11 | — | — | CN | claimed |
| US-20210348007-A1 | METHOD FOR PRINTING | CANON PRODUCTION PRINTING HOLDING B.V. (NL) | 2021-11-11 | — | — | US | claimed |
| US-20150190330-A1 | DENTAL ADHESIVE COMPOSITION | DENTSPLY INT INC (US) | 2015-07-09 | — | — | US | claimed |
| US-8431742-B2 | Method for producing dodeca-2,10-diene-1,12-dicarboxylic acid or 1,12-dodecane-dicarboxylic acid by way of ring-opening cross metathesis (ROCM) of cyclooctene with acrylic acid | EVONIK DEGUSSA GMBH (DE) | 2013-04-30 | — | — | US | claimed |
| US-20100130635-A1 | Dental adhesive composition | BLACKWELL GORDON B | 2010-05-27 | — | — | US | claimed |
| EP-1771141-B1 | DENTAL ADHESIVE COMPOSITION | DENTSPLY DETREY GMBH (DE) | 2009-03-25 | — | — | EP | claimed |
| US-20080004365-A1 | Dental Adhesive Composition | DENTSPLY DETREY GMBH (DE) | 2008-01-03 | — | — | US | claimed |
| US-5085697-A | Applying photosensitive ink on substrate; curing | HAYAKAWA RUBBER CO., LTD. (JP) | 1992-02-04 | — | — | US | claimed |
| US-4929469-A | SCREEN PRINTING, ULTRAVIOLET CURABLE RUBBERY COATING | HAYAKAWA RUBBER CO., LTD. (JP) | 1990-05-29 | — | — | US | claimed |
| US-11884002-B2 | Additive manufacturing of hierarchical three- dimensional micro-architected aerogels | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-01-30 | — | — | US | disclosed |
| US-11880133-B2 | Architected three dimensional graphene via additive manufacturing | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-01-23 | — | — | US | disclosed |
| EP-4130064-A1 | EXPANDABLE METHYL-METHACRYLATE-BASED RESIN PARTICLES, METHYL-METHACRYLATE-BASED EXPANDED PARTICLES, METHYL-METHACRYLATE-BASED MOLDED FOAM, AND EVAPORATIVE PATTERN | Kaneka Corporation (JP) | 2023-02-08 | — | — | EP | disclosed |
| US-20230022682-A1 | EXPANDABLE METHYL-METHACRYLATE-BASED RESIN PARTICLES, METHYL-METHACRYLATE-BASED EXPANDED PARTICLES, METHYL-METHACRYLATE-BASED MOLDED FOAM, AND EVAPORATIVE PATTERN | KANEKA CORPORATION (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-07-14 | — | — | US | disclosed |
| US-6579618-B1 | Optical fiber comprising coating obtained by curing composition including polymer with urethane bonds in chain and unsaturated groups, monomer having two or three unsaturated groups, monomer having one acryloyl group, initiator | DSM N.V. (NL) | 2003-06-17 | — | — | US | disclosed |
| US-5085697-A | Applying photosensitive ink on substrate; curing | HAYAKAWA RUBBER CO., LTD. (JP) | 1992-02-04 | — | — | US | disclosed |
| US-4929469-A | SCREEN PRINTING, ULTRAVIOLET CURABLE RUBBERY COATING | HAYAKAWA RUBBER CO., LTD. (JP) | 1990-05-29 | — | — | US | disclosed |
| US-4640938-A | Radiation-curable composition, a process for preparing same, and the use thereof | MORTON THIOKOL GMBH (DE) | 1987-02-03 | — | — | US | disclosed |
| EP-0143903-B1 | RADIATION-CURABLE COMPOSITION, A PROCESS FOR PREPARING SAME, AND THE USE THEREOF | Morton Thiokol GmbH (DE) | 1986-10-15 | — | — | EP | disclosed |
| EP-0143903-A1 | Radiation-curable composition, a process for preparing same, and the use thereof | Morton Thiokol GmbH (DE) | 1985-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | PPOX, CYBA, CYBB | PTPN1 4647/4885TBXAS1 2810/4885BLM 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.